Up 58% in 12 Months, This Is Where Rocket Lab Will End The Year
Rocket Lab has handed investors a 58% gain over the past year, then turned around and erased nearly 30% of its value in a single month. Where a $2.2 billion backlog, a looming Neutron debut, and a Golden Dome defense…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Space stocks have been volatile, and Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) captures that whiplash well. Shares have gained 58.13% over the past 12 months, but the last four weeks have reversed course. That sets up the year-end question our model addresses.
RKLB currently trades at $70.43. Based on our proprietary model, the 24/7 Wall St. price target for RKLB is $81.63 by year-end 2026, roughly 15.9% above current levels. Our recommendation is buy, with a moderate confidence level of 50% reflecting elevated volatility.
24/7 Wall St. Price Target Summary
| Metric | Value |
|---|---|
| Current Price | $70.43 |
| 24/7 Wall St. Price Target (Year-End 2026) | $81.63 |
| Implied Upside | 15.9% |
| Recommendation | BUY |
| Confidence Level | 50% |
A Whiplash Summer for a Defense-Tech Darling
RKLB is up 5.21% over the past week but has fallen 29.89% in the past month after peaking near $124.77 in mid-May. The stock sits 24% below its 52-week high of $151 yet still trades far above the $37.57 low. A recent r/wallstreetbets thread titled “RKLB down 35% in a month on zero bad news, generational buying opportunity or are we the exit liquidity?” drew more than 1,100 upvotes.
Fundamentals support the buyers. Q1 FY26 revenue of $200.35 million grew 63.5% year over year and beat consensus by 5.77%, while non-GAAP gross margin expanded to 43% from 33.4%. Backlog reached a record $2.20 billion, and Q2 guidance calls for revenue of $225M to $240M.
CEO Peter Beck confirmed selection for the Department of Defense’s Space Based Interceptor program under Golden Dome for America in partnership with Raytheon.
The Case for $95+
Bulls have substantial catalysts. Rocket Lab signed 31 new Electron and HASTE launch agreements plus five Neutron missions in Q1 alone, and the $816 million SDA Tranche 3 contract remains the largest in company history. Neutron, the medium-lift vehicle, is targeting a debut launch later in 2026.
A clean first flight would validate a competitive alternative to Falcon 9 and unlock a total launch manifest already exceeding 70 contracted missions. Our bull case takes RKLB to $95.07 by December, and Wall Street analysts show 3 Strong Buys and 11 Buys against just 3 Holds.
What Could Go Wrong
The bear case starts with cash burn. FY25 delivered a net loss of $198.2 million on $601.8 million in revenue, and Q1 FY26 required $450 million raised through an ATM equity offering. Neutron slipped once already after a stage-1 tank test failure pushed the debut to Q4 2026. Any further delay would rattle the story.
Prediction markets flag near-term skepticism: Polymarket shows only a 34.5% probability RKLB beats its next quarterly earnings. Insider activity has skewed toward net selling across 91 recent transactions.
Our bear case lands at $77.83 by year-end. The dilution reflects a deliberate build-out ahead of Neutron and Golden Dome revenues, and non-GAAP gross margin has climbed nearly 10 points year over year.
How Rocket Lab Compares to AST SpaceMobile and Planet Labs
AST SpaceMobile (NASDAQ:ASTS) is a satellite play with a $17.5 billion market cap but only $14.73 million in Q1 2026 revenue. Against RKLB’s $679.6 million trailing revenue and $40.6 billion market cap, ASTS trades at a dramatically higher revenue multiple with a fraction of the operating scale. Our 24/7 Wall St. price target looks conservative on relative revenue economics.
Planet Labs (NYSE:PL) is a closer commercial analog. Planet guided FY27 revenue of $425M to $441M with backlog above $906 million and a $7.17 billion market cap. RKLB commands roughly 5x that market cap on a comparable growth trajectory, but with Neutron optionality and a larger backlog. On a growth-adjusted basis, RKLB looks fair.
Rocket Lab Price Prediction 2026-2030
The 24/7 Wall St. price target of $81.63 by December 2026 points to modest but meaningful appreciation, with 50% confidence. The factor tipping the scale is backlog.
When contracted work grew 73% year over year to $1.85 billion in 2025 and jumped again in Q1, the setup for the second half looks defensible. The bull scenario strengthens if Neutron stays on schedule for a Q4 debut. The bear scenario gains traction if the next earnings report shows margin compression. On balance, the risk-reward skews positive.
Here is where our model projects RKLB could trade, assuming current growth and margin trajectories hold.
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $81.63 |
| 2027 | $124.43 |
| 2028 | $178.00 |
| 2029 | $245.00 |
| 2030 | $331.69 (2031 base) |
These projections assume Rocket Lab executes on Neutron, Golden Dome, and its SDA-linked satellite constellation programs. Significant upside or downside could result from Neutron reusability milestones, defense budget swings tied to the FY 2027 Space-Based Systems total of $59.7 billion, or execution stumbles on the acquisition integration front.
Contact [email protected] for any questions or corrections.
Vandita Jadeja is a financial publisher with over a decade of experience writing about financial topics, including investment, savings, retirement, insurance and banking. Vandita is a Chartered Accountant who loves to debunk financial concepts for readers.
Her work has appeared on sites that include The Motley Fool, InvestorPlace, and Benzinga. She covers investing and focuses on stock picks and price prediction for 24/7 Wall St.
When not looking for the next stock investment opportunity, she can be found traveling, reading, chasing sunsets and enjoying her iced latte.
